[Pharmaceutical characterization and spectroscopy of Bonnecor (AWD 19-166, GS 015)].
To describe the pharmaceutical behaviour of Bonnecor methods and results of testing identity, purity, content and stability are presented. Spectroscopical analyses are needed for costitutionel examination of the molecule and of some possible metabolites.
D000889:Anti-Arrhythmia Agents / Q000032:analysis*; D055598:Chemical Phenomena; D002621:Chemistry; D002855:Chromatography, Thin Layer; D003984:Dibenzazepines / Q000032:analysis*; D004355:Drug Stability; D008027:Light; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet; D013696:Temperature
D000889:Anti-Arrhythmia Agents; D003984:Dibenzazepines; C048166:tiracizine
Pharmazeutische Charakterisierung und Spektroskopie von Bonnecor (AWD 19-166, GS 015).